WELLS FARGO & COMPANY/MN - PEREGRINE PHARMACEUTICALS IN ownership

PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 85 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of PEREGRINE PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$206,000
+38.3%
338,378
+48.0%
0.00%
Q1 2017$149,000
+1141.7%
228,628
+495.7%
0.00%
Q4 2016$12,000
-73.9%
38,378
-63.9%
0.00%
Q3 2016$46,000
+17.9%
106,3780.0%0.00%
Q2 2016$39,000
-44.3%
106,378
-35.5%
0.00%
Q1 2016$70,000
-61.5%
165,010
+5.5%
0.00%
Q4 2015$182,000
+13.8%
156,415
+0.0%
0.00%
Q3 2015$160,000
-21.6%
156,362
+0.4%
0.00%
Q2 2015$204,000
-13.6%
155,667
-11.1%
0.00%
Q1 2015$236,000
+112.6%
175,104
+118.0%
0.00%
Q4 2014$111,000
+640.0%
80,332
+626.0%
0.00%
Q3 2014$15,000
-53.1%
11,065
-36.4%
0.00%
Q2 2014$32,000
+357.1%
17,405
+369.1%
0.00%
Q1 2014$7,000
+40.0%
3,710
-5.1%
0.00%
Q4 2013$5,000
+25.0%
3,910
+16.9%
0.00%
Q3 2013$4,0000.0%3,345
-5.6%
0.00%
Q2 2013$4,0003,5450.00%
Other shareholders
PEREGRINE PHARMACEUTICALS IN shareholders Q2 2014
NameSharesValueWeighting ↓
BAXTER BROS INC 170,506$232,0000.09%
First Heartland Consultants, Inc. 86,204$117,0000.05%
Rotella Capital Management, Inc. 20,769$28,0000.03%
FIDGEON TIMOTHY F 33,000$45,0000.02%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 547,800$746,0000.02%
Freedom Investment Management, Inc. 74,127$101,0000.02%
Investors Capital Advisory Services 63,288$86,0000.02%
REYNOLDS CAPITAL MANAGEMENT LLC 10,000$14,0000.01%
Tower Research Capital LLC (TRC) 76,914$104,0000.01%
PINNACLE FINANCIAL PARTNERS INC 20,000$27,0000.01%
View complete list of PEREGRINE PHARMACEUTICALS IN shareholders